![PDF] Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7896471207c8fe77bab199b437597b9ca881227b/6-TableIV-1.png "PDF] Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma | Semantic Scholar")
PDF] Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma | Semantic Scholar
Diagnostics | Free Full-Text | Circulating Tumor Cells for the Management of Renal Cell Carcinoma
![PDF] Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7896471207c8fe77bab199b437597b9ca881227b/5-TableIII-1.png "PDF] Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma | Semantic Scholar")
PDF] Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma | Semantic Scholar
Marker-based RCC CSC phenotypes | Download Table
GRP78 expression in tumor and perinephric adipose tissue is not an optimal risk stratification marker for clear cell renal cell carcinoma | PLOS ONE
Renal Tumor Immunomarkers Identified with Microarrays. | Download Table
![PDF] Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b0000f8669cdd72c257fa6d3b2954b9a91f4eede/4-Table2-1.png "PDF] Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma. | Semantic Scholar")
PDF] Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma. | Semantic Scholar
![PDF] Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7896471207c8fe77bab199b437597b9ca881227b/4-TableII-1.png "PDF] Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma | Semantic Scholar")
PDF] Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma | Semantic Scholar
Expression of CD105 cancer stem cell marker in three subtypes of renal cell carcinoma. | Semantic Scholar
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma - ScienceDirect
c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma. | Semantic Scholar
Active surveillance of small renal masses | Insights into Imaging | Full Text
Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach - eBioMedicine
PDF) Determination of pyruvate kinase type tumor M2 in human renal cell carcinoma: a suitable tumor marker? | Thomas Stief - Academia.edu
Renal-Cell Carcinoma | NEJM
Cancers | Free Full-Text | Comprehensive Immunoprofiles of Renal Cell Carcinoma Subtypes
Frontiers | Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer
The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications | Nature Reviews Urology
Quick Reference: RCC Category II Markers | Download Table
Renal cell carcinoma - Knowledge @ AMBOSS
Frontiers | Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma
Prospects for Targeting PD-1 and PD-L1 in Various Tumor Types
![PDF] Immunohistochemical Markers for Metastasis in Clear Cell Renal Cell Carcinoma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/48c86333494c2ad4bde0c4f5862a44022eb0fd33/3-Table1-1.png "PDF] Immunohistochemical Markers for Metastasis in Clear Cell Renal Cell Carcinoma | Semantic Scholar")
PDF] Immunohistochemical Markers for Metastasis in Clear Cell Renal Cell Carcinoma | Semantic Scholar
